This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Belhassen, B. Articles by Eldar, M. Search for Related Content PubMed PubMed Citation Articles by Belhassen, B. Articles by Eldar, M.

CLINICAL STUDY

Adenosine-5'-triphosphate test for the noninvasive diagnosis of concealed accessory pathway

^a Departments of Cardiology, Tel-Aviv Sourasky, Tel-Aviv, Israel
^* Chaim Sheba Medical Centers, and Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel

Manuscript received August 20, 1999; revised manuscript received March 1, 2000, accepted April 12, 2000.

Reprint requests and correspondence to: Dr. Bernard Belhassen, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Weizman Street 6, Tel-Aviv 64239, Israel
bblhass{at}tasmc.health.gov.il

OBJECTIVES

This study assessed the use of adenosine triphosphate (ATP) in the noninvasive diagnosis of concealed accessory pathway (AP) and dual atrioventricular (AV) node physiology in patients with inducible AV reentrant tachycardia (AVRT).

BACKGROUND

Administration of ATP during sinus rhythm identifies dual AV node physiology in 76% of patients with inducible sustained slow/fast AV nodal reentry tachycardia (AVNRT).

METHODS

Incremental doses of ATP were intravenously administered during sinus rhythm to 34 patients with inducible sustained AVRT involving a concealed AP and to 27 control patients without AP or dual AV node physiology. One study group patient could not complete the study and was excluded from analysis.

RESULTS

The AV reentrant echo beats (AVRE), or AVRT, suggestive of the presence of concealed AP, were observed after ATP administration in 24 (73%) study patients and in none of the control group. Electrocardiographic signs suggestive of dual AV node physiology were observed after ATP administration in 7 (21%) study patients and in none of the control group. Most instances of AVRE/AVRT were preceded by a slight increase (<50 ms) in PR interval. In 8 of 9 patients tested, neither AVRE nor AVRT was no longer observed following ATP administration after successful radiofrequency ablation of the AP. In the remaining patient, a different AVRE due to the presence of an additional AP was observed.

CONCLUSIONS

Administration of ATP during sinus rhythm may be a useful bedside test for identifying patients with concealed AP who are prone to AVRT and those with associated dual AV node pathways.

Abbreviations and Acronyms   AP = accessory pathway   ATP = adenosine triphosphate   AV = atrioventricular   AVNRT = atrioventricular nodal reentry tachycardia   AVRE = atrioventricular reentrant echo beats   AVRT = atrioventricular reentrant tachycardia   ECG = electrocardiographic   PSVT = paroxysmal supraventricular tachycardia

This article has been cited by other articles:

				M. Eisenberger, N. C. Davidson, D. M. Todd, C. J. Garratt, and A. P. Fitzpatrick A new approach to confirming or excluding ventricular pre-excitation on a 12-lead ECG Europace, November 9, 2009; (2009) eup345v1. [Abstract] [Full Text] [PDF]

				G. Burnstock Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev., March 1, 2006; 58(1): 58 - 86. [Abstract] [Full Text] [PDF]

				M L Mallet Proarrhythmic effects of adenosine: a review of the literature Emerg. Med. J., July 1, 2004; 21(4): 408 - 410. [Abstract] [Full Text] [PDF]

				S C Toal, B U Vajifdar, A K Gupta, A M Vora, and Y Y Lokhandwala Adenosine induced PR jump on surface ECG to differentiate atrioventricular nodal re-entrant tachycardia from concealed accessory pathway mediated tachycardia: a bedside test Heart, January 1, 2002; 87(1): 37 - 40. [Abstract] [Full Text] [PDF]

				S. Viskin, R. Fish, A. Glick, M. Glikson, M. Eldar, and B. Belhassen The adenosine triphosphate test: a bedside diagnostic tool for identifying the mechanism of supraventricular tachycardia in patients with palpitations J. Am. Coll. Cardiol., July 1, 2001; 38(1): 173 - 177. [Abstract] [Full Text] [PDF]